74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Debes considerar si comprendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Debes considerar si comprendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
Thermo Fisher Scientific Inc
Cerrado
SectorSanidad
468.85 0.36
Resumen
Variación precio
24h
Mínimo
466.38
Máximo
470.35
Ingresos | 349M 2B |
|---|---|
Ventas | 1.1B 12B |
P/B Media del Sector | 29.668 60.328 |
Rentabilidad por dividendo | 0.33 |
Margen de beneficios | 16.128 |
Empleados | 125,000 |
EBITDA | 377M 3.2B |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 Meses | +34.73% upside |
Rentabilidad por dividendo Media del Sector | 0.33% 2.24% |
|---|---|
Próximas Ganancias | 22 jul 2026 |
Fecha Próximo Dividendo | 14 jul 2026 |
Próxima Fecha de Ex Dividendo | 12 jun 2026 |
Capitalización Mercado | -40B 195B |
|---|---|
Apertura anterior | 468.49 |
Cierre anterior | 468.85 |
Puntuación técnica
By Trading Central
Confianza
Bearish Evidence
Thermo Fisher Scientific Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Thermo Fisher Scientific Inc previsión
Precio Objetivo
By TipRanks
34.73% repunte
Estimación a 12 Meses
Media 632.83 USD 34.73%
Máximo 685 USD
Mínimo 575 USD
De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Thermo Fisher Scientific Inc Dist en los últimos 3 meses.
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
